Success Metrics

Clinical Success Rate
100.0%

Based on 11 completed trials

Completion Rate
100%(11/11)
Active Trials
0(0%)
Results Posted
55%(6 trials)

Phase Distribution

Ph not_applicable
1
9%
Ph phase_1
5
45%
Ph phase_2
2
18%
Ph phase_3
2
18%
Ph phase_4
1
9%

Phase Distribution

5

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
5(45.5%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
2(18.2%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
1(9.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

11 of 11 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(11)

Detailed Status

Completed11

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (45.5%)
Phase 22 (18.2%)
Phase 32 (18.2%)
Phase 41 (9.1%)
N/A1 (9.1%)

Trials by Status

completed11100%

Recent Activity

Clinical Trials (11)

Showing 11 of 11 trials
NCT02574845Phase 1

DDI (Effect of Metformin and Furosemide on Rosuvastatin PK)

Completed
NCT03398824Phase 2

Pilot Study of Metformin for Patients With Fanconi Anemia

Completed
NCT03259490Phase 1

This Study Tests Whether Taking the Medicines Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills. The Study is Done in Healthy Men and Women and Measures the Amount of Each Medicine in the Blood

Completed
NCT03629054Phase 1

This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills

Completed
NCT01890122Phase 3

Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes

Completed
NCT00005669Phase 2

Metformin to Treat Obesity in Children With Insulin Resistance

Completed
NCT00612144Phase 4

Study Comparing Efficacy and Safety of Amaryl M and Metformin Uptitraion to Type 2 DM

Completed
NCT00187798Not Applicable

Impact of Genetics on Metformin Pharmacokinetics

Completed
NCT00035542Phase 3

A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.

Completed
NCT00944177Phase 1

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fasted, Healthy, Adult Subjects

Completed
NCT00944346Phase 1

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subjects

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11